Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Japan”
Sponsor: EMD Serono Research & Development Institute, Inc.
Metastatic Colorectal Cancer
United States, Argentina, Australia, Austria, Belgium +11 more
Sponsor: Genmab
Advanced Malignant Solid Tumors · Metastatic Malignant Solid Tumors
United States, Japan, Spain
Sponsor: Genmab
Ovarian Cancer · Platinum-sensitive Ovarian Cancer · PSOC
United States, Belgium, Japan
Sponsor: Merck Sharp & Dohme LLC
Coronavirus Disease (COVID-19)
United States, Argentina, Brazil, Bulgaria, Colombia +19 more
Sponsor: Ipsen
Moderate to Severe Glabellar Lines
United States, France, Germany, Japan
Sponsor: Merck Sharp & Dohme LLC
Non-small Cell Lung Cancer
United States, Argentina, Australia, Brazil, China +11 more
Sponsor: Novo Nordisk A/S
Obesity · Overweight · Obstructive Sleep Apnoea
United States, Australia, China, Germany, India +5 more
- Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)Active Not Recruiting
Sponsor: Tanabe Pharma America, Inc.
EPP · XLP
United States, Australia, Bulgaria, Canada, Czechia +10 more
- Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06)Active Not Recruiting
Sponsor: Genmab
PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC
United States, Argentina, Australia, Austria, Belgium +22 more
Sponsor: AbbVie
Waldenstrom Macroglobulinemia · Lymphoplasmacytic Lymphoma
Japan
- A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia AActive Not Recruiting
Sponsor: Novo Nordisk A/S
Haemophilia A · Haemophilia A With Inhibitors
United States, Austria, Belgium, Bulgaria, Canada +27 more
Sponsor: GlaxoSmithKline
Gastrointestinal Neoplasms
Japan
Sponsor: Hoffmann-La Roche
Von Willebrand Disease, Type 3
United States, Belgium, Canada, Colombia, France +9 more
- First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC)Active Not Recruiting
Sponsor: Amgen
Extensive Stage Small Cell Lung Cancer
United States, Australia, Belgium, Canada, Denmark +10 more
Sponsor: Merck Sharp & Dohme LLC
Crohn's Disease
United States, Australia, Austria, Belgium, Brazil +42 more
- MDT-0123 Japan StudyRecruiting
Sponsor: Medtronic Spinal and Biologics
Disc Degeneration · Spinal Deformity
Japan
Sponsor: Generate Biomedicines
Severe Asthma
United States, Argentina, Australia, Belgium, Estonia +9 more
Sponsor: Eli Lilly and Company
Ulcerative Colitis
United States, Austria, Brazil, Canada, China +12 more
Sponsor: Ono Pharmaceutical Co., Ltd.
Polycythemia Vera
United States, Australia, Japan
Sponsor: AstraZeneca
Chronic Lymphocytic Leukaemia · Small Lymphocytic Lymphoma · Mantle-cell Lymphoma · Large B-cell Lymphoma
United States, Australia, China, Czechia, Denmark +8 more
Sponsor: Eli Lilly and Company
Carcinoma, Non-Small-Cell Lung · Neoplasm Metastasis
United States, Australia, Austria, Belgium, Brazil +24 more
- A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)Recruiting
Sponsor: Eli Lilly and Company
Irritable Bowel Syndrome · Diarrhea
United States, Belgium, Canada, China, Germany +5 more
Sponsor: Eli Lilly and Company
Urinary Incontinence,Stress
United States, Canada, China, Czechia, India +5 more
Sponsor: Ono Pharmaceutical Co., Ltd.
Pediatric Malignant Solid Tumor and Epithelioid Sarcoma
Japan
Sponsor: Eli Lilly and Company
Sleep Apnea, Obstructive · Obesity · Overweight
United States, Australia, Brazil, Canada, China +6 more